Rarecells
Isolating Circulating Cancer Cells
- B2B
About Rarecells
Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2010
- Revenue
- $6.3M – $50MTamtam estimate
- Website
- rarecells.com
- linkedin.com/company/rarecells
Rarecells at a glance
Rarecells is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Rarecells was founded in 2010.
Rarecells has 11–50 employees.
Rarecells's revenue is $6.3M – $50M (Tamtam estimate).
Selling to companies like Rarecells?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies